#her2 breast cancer

New Role Discovered for Mutant Protein Found in Most Breast Cancers

3d rendering medical illustration of the human breast

Some Postmenopausal Women Can Skip Additional Chemotherapy

October is Breast Cancer Awareness Month

Breast Cancer 101

New Role Discovered for Mutant Protein Found in Most Breast Cancers

Some Postmenopausal Women Can Skip Additional Chemotherapy

Breast Cancer 101

HER2-Low Breast Cancer

The results could also be relevant for people with other types of HER2-low cancer.

Enhertu Works for HER2-Low Metastatic Breast Cancer Too

The antibody-drug conjugate improved progression-free and overall survival for patients with low HER2 expression on breast tumors.

New Findings About Breast Cancers With Low Levels of HER2 Protein

Researchers at Dana-Farber Cancer Institute show that “HER2-low” tumors are not a distinct subtype of breast cancer.

Using Big Data to Better Understand Cancerous Mutations

Artificial intelligence and machine learning can help identify genetic changes that lead to cancer—and which treatments work best.

New Biomarker Classification May Improve Treatment of High-Risk Breast Cancer

The new cancer subtypes help better characterize a person’s tumor. The goal is to get the right drug to the right patient.

When Breast Cancer Spreads to the Brain: What You Need to Know

A look at the symptoms, treatments, risk factors, prognosis and research on breast cancer metastasis to the brain.

Now Approved

Here are latest cancer drugs approved by the Food and Drug Administration.

Margenza

FDA Approves Margenza for Metastatic HER2-Positive Breast Cancer

Monoclonal antibody delays disease progression in people with previously treated HER2-positive tumors.

Could Honeybee Venom Lead to a Breast Cancer Drug?

The honeybee’s sting contains a compound that kills hard-to-treat breast cancer cells quickly.

Verzenio Prevents Recurrence and Metastasis of Early Breast Cancer

The oral targeted therapy lowered the risk of relapse in a late-stage study.

Now Approved

Here are latest arrivals approved by the Food and Drug Administration.

Phesgo

FDA Approves Breast Cancer Treatment That Can Be Administered at Home

New injectable combination can be administered by health care providers outside medical centers.

Hani Sbitany, MD, a plastic and reconstructive surgeon at UCSF Health, performs a breast reconstruction surgery. Sbitany is one of a few surgeons using a procedure that is less invasive and has a less painful recovery.

Surgery for Metastatic Breast Cancer Does Not Improve Overall Survival

A new randomized study sought to clarify results from previous studies that suggested there would be a benefit from such local treatment.

Special Delivery: Antibody-Drug Conjugates

Last year, the FDA approved three new antibody-drug conjugates for treating cancer.

#her2 breast cancer

New Role Discovered for Mutant Protein Found in Most Breast Cancers

Some Postmenopausal Women Can Skip Additional Chemotherapy

Breast Cancer 101

New Role Discovered for Mutant Protein Found in Most Breast Cancers

Some Postmenopausal Women Can Skip Additional Chemotherapy

Breast Cancer 101

HER2-Low Breast Cancer

Enhertu Works for HER2-Low Metastatic Breast Cancer Too

New Findings About Breast Cancers With Low Levels of HER2 Protein

Using Big Data to Better Understand Cancerous Mutations

New Biomarker Classification May Improve Treatment of High-Risk Breast Cancer

When Breast Cancer Spreads to the Brain: What You Need to Know

Now Approved

Margenza

FDA Approves Margenza for Metastatic HER2-Positive Breast Cancer

Could Honeybee Venom Lead to a Breast Cancer Drug?

Verzenio Prevents Recurrence and Metastasis of Early Breast Cancer

Now Approved

Phesgo

FDA Approves Breast Cancer Treatment That Can Be Administered at Home

Surgery for Metastatic Breast Cancer Does Not Improve Overall Survival

Special Delivery: Antibody-Drug Conjugates

Science News

Features